Cancer Clinical Trial - Pfizer C3881001

Status:

Open

ClinicalTrials.gov:

NCT03685591

A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF 06952229 IN ADULT PATIENTS WITH ADVANCED SOLID TUMORS

Drug

PF-06952229

Trial Type

Interventional

Phase

Phase 1

Condition

Melanoma

Keywords

Melanoma | Pfizer C3881001